Prostate Cancer
Recent Abstracts
Prostate-specific antigen 1.5-4.0 ng/mL: A diagnostic challenge and danger zone - Abstract
July 18, 2011
Location of residual cancer after transrectal high-intensity focused ultrasound ablation for clinically localized prostate cancer - Abstract
July 18, 2011
Phase II study of carboplatin and etoposide in patients with anaplastic progressive metastatic castration-resistant prostate cancer (mCRPC) with or without neuroendocrine differentiation: Results of the French Genito-Urinary Tumor Group (GETUG) P01 trial
July 18, 2011
Editor's Commentary - Phase II study of carboplatin and etoposide in patients with anaplastic progressive metastatic castration-resistant prostate cancer (mCRPC) with or without neuroendocrine differentiation: Results of the French Genito-Urinary Tumor Gr
July 18, 2011
Editor's Commentary - The relationship between prostate specific antigen change and biopsy progression in patients with prostate cancer on active surveillance
July 18, 2011
Single-arc volumetric-modulated arc therapy can provide dose distributions equivalent to fixed-beam intensity-modulated radiation therapy for prostatic irradiation with seminal vesicle and/or lymph node involvement - Abstract
July 17, 2011
The role of vitamin D, estrogen, calcium sensing receptor genotypes and serum calcium in the pathogenesis of prostate cancer - Abstract
July 15, 2011
Potential prostate cancer drug target: Bioactivation of androstanediol by conversion to dihydrotestosterone - Abstract
July 15, 2011
Outcome, clinical prognostic factors and genetic predictors of adverse reactions of intermittent combination chemotherapy with docetaxel, estramustine phosphate and carboplatin for castration-resistant prostate cancer - Abstract
July 15, 2011
Predictive models for worsening prognosis in potential candidates for active surveillance of presumed low-risk prostate cancer - Abstract
July 15, 2011
Enhanced antitumor activity of low-dose continuous administration schedules of topotecan in prostate cancer - Abstract
July 15, 2011
Diabetes and prostate cancer risk in the REDUCE trial - Abstract
July 15, 2011
Lateral spine radiographs before androgen deprivation treatment detect a high incidence of undiagnosed vertebral fragility fractures in men with advanced prostate cancer - Abstract
July 14, 2011
Multi-parametric magnetic resonance imaging to rule-in and rule-out clinically important prostate cancer in men at risk: A cohort study - Abstract
July 14, 2011
New findings in localized and advanced prostate cancer: AUA 2011 review - Abstract
July 14, 2011
Protein-coding and microRNA biomarkers of recurrence of prostate cancer following radical prostatectomy - Abstract
July 14, 2011
The Cancer of the Prostate Risk Assessment (CAPRA) in patients treated with external beam radiation therapy: Evaluation and optimization in patients at higher risk of relapse - Abstract
July 14, 2011
Predictors of unfavourable repeat biopsy results in men participating in a prospective active surveillance program - Abstract
July 14, 2011
Development of improved nomogram for prediction of outcome of initial prostate biopsy using readily available clinical information - Abstract
July 14, 2011
Association of clinical benign prostate hyperplasia with prostate cancer incidence and mortality revisited: A nationwide cohort study of 3 009 258 men - Abstract
July 14, 2011
Page 1359 of 1420
Start
Prev
1354
1355
1356
1357
1358
1359
1360
1361
1362
1363
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free